| Financial Year |
March 31 2023 |
| Monetary Funds |
66,553,920.46 |
| Held-for-trading Financial Assets |
4,210,000.00 |
| Notes Receivable |
181,435,984.59 |
| Accounts Receivable |
687,513,124.45 |
| Advances to Suppliers |
131,148,356.24 |
| Other Receivables |
134,860,732.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
251,604,178.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,276,549.79 |
| Total Current Assets |
1,468,040,078.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
78,527,069.47 |
| Investment Properties |
52,160,200.00 |
| Fixed Assetes |
239,097,111.74 |
| Under-construction Projects |
3,831,678.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
112,134,045.02 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,688,284.43 |
| Deferred Income Tax Assets |
19,711,860.86 |
| Other Non-Current Assets |
7,458,744.23 |
| Sub-Total of Non-Current Assets |
541,383,027.63 |
| Total Assets |
2,009,423,105.91 |
| Short-Term Loans |
199,474,274.84 |
| Trading Financial liabilities |
-- |
| Notes Payable |
23,810,000.00 |
| Accounts Payable |
275,108,106.34 |
| Accounts Received In Advance |
3,869,123.20 |
| Employee Compensation Payable |
26,769,096.70 |
| Taxes Payable |
30,028,313.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
269,572,712.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,373,506.52 |
| Other Current Liabilities |
107,357,028.81 |
| Sub-Total of Current Liabilities |
1,046,311,663.91 |
| Long-term Loans |
600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,229,558,336.49 |
| Deferred Income Tax Liabilities |
4,442,149.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,278,346,586.11 |
| Total Liabilities |
3,324,658,250.02 |
| Paid-In Capital(Or Share Stock) |
1,099,911,762.00 |
| Capital Surplus |
1,081,914,745.12 |
| Surplus Reserve |
92,910,942.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,607,350,284.27 |
| Minority Stockholder's Interest |
10,178,316.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-1,325,413,460.93 |
| Owner's Equity（Stockholder's Equity） |
-1,315,235,144.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,009,423,105.91 |
